The Effect of Dietary Lauric Acid on the Production of the LRH-1 Ligand, Dilauroylphosphatidylcholine
DLauricPC
Production of a LRH-1 Ligand in Humans: A Randomized,Controlled, Cross-Over Feeding Trial
1 other identifier
interventional
10
1 country
1
Brief Summary
A phosphatidylcholine species enriched with lauric acid at both the sn-1 and sn-2 positions, dilauroylphosphatidylcholine (DLPC), was recently identified as a ligand for the nuclear receptor, liver receptor homolog-1 (LRH-1). To date, DLPC has not been reported in vitro or in vivo, and has yet to be catalogued in the human metabolomics database. This intervention trial aims to determine the impact of consumption of dietary lauric acid, in the form of coconut oil (49% lauric acid), can facilitate the production of DLPC in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2018
CompletedStudy Start
First participant enrolled
March 19, 2018
CompletedFirst Posted
Study publicly available on registry
March 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2018
CompletedMarch 22, 2022
March 1, 2022
24 days
March 8, 2018
March 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DLPC in Postprandial Serum
The presence of DLPC in postprandial serum will be measured using Liquid Chromatography Tandem Mass Spectrometry
6 hours postprandial
Secondary Outcomes (1)
Serum Total Bile Acids
6 hours postprandial
Study Arms (2)
Olive Oil Shake
ACTIVE COMPARATORIntervention: No Lauric Acid A breakfast shake made from a complete meal shake will be prepared with water and supplemented with 2 tablespoons of olive oil.
Coconut Oil Shake
EXPERIMENTALIntervention: Lauric Acid A breakfast shake made from a complete meal shake will be prepared with water and supplemented with 2 tablespoons of coconut oil.
Interventions
A breakfast shake made from a complete meal shake will be prepared with water and supplemented with 2 tablespoons of coconut oil.
A breakfast shake made from a complete meal shake will be prepared with water and supplemented with 2 tablespoons of olive oil.
Eligibility Criteria
You may qualify if:
- Willingness to comply with the study protocol
- Ability to overnight fast
- Willingness to donate blood
- 'generally healthy'
You may not qualify if:
- self-reported regular consumption of tropical oils or supplements containing lauric acid
- self-reported food allergies to shake ingredients
- medical conditions where blood draws or fasting may be contraindicated
- major gastrointestinal conditions, such as inflammatory bowel disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Human Metabolic Research Unit, Cornell University
Ithaca, New York, 14853, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be blinded to the intervention oil (single-blind).
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2018
First Posted
March 29, 2018
Study Start
March 19, 2018
Primary Completion
April 12, 2018
Study Completion
April 22, 2018
Last Updated
March 22, 2022
Record last verified: 2022-03